Search
Search Results
##search.searchResults.foundPlural##
-
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2150PDF: 1710HTML: 380 -
-
Parvovirus B19-triggered acute hemolytic anemia and thrombocytopenia in a child with Evans syndrome
3545PDF: 991HTML: 432Table 1.: 231 -
The diagnostic pitfalls of mucormycosis
934PDF: 726HTML: 256 -
A 9month-old-boy with atypical hemophagocytic lymphohistiocytosis
2034PDF: 805HTML: 1102 -
TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
3358PDF: 1480HTML: 4014 -
NPM1 MUTATED, BCR-ABL1 POSITIVE MYELOID NEOPLASMS: REVIEW OF LITERATURE NPM1 mutated, BCR-ABL1 positive myeloid neoplasms
1715PDF: 1194HTML: 232 -
The diagnostic sensitivity of beta-D-glucan assay in patients with chronic disseminated candidiasis
1310PDF: 1094PDF: 875HTML: 172 -
Sickle cell disease and Bartonella spp. infection
1190PDF: 876HTML: 458 -
MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT
856PDF: 487HTML: 1307 -
Interstitial pneumonia triggered by H1N1 influenza A virus as the initial presentation of chronic myeloid leukemia
891PDF: 489HTML: 141Suppl. Files: 326 -
Acquired Hemophilia A successfully treated with rituximab
1956PDF: 1152HTML: 1459Figure 1: 180 -
miR-155-5p PROMOTES CD34+ APOPTOSIS AND INHIBITS BONE MARROW HEMATOPOIESIS IN MYELODYSPLASTIC SYNDROMES BY RAC1/CREB/MIR-15B AXIS
744PDF: 866PDF Supp. Files: 78HTML: 191 -
THERAPEUTIC GENE EDITING FOR HEMOGLOBINOPATHIES Gene therapy for Hemoglobinopathies.
2170PDF: 1307Html: 290 -
TREATMENT OF INDOLENT AND ADVANCED SYSTEMIC MASTOCYTOSIS Systemic Mastocytosis Treatment
2114PDF: 1533HTML: 499 -
HEPATITIS C VIRUS INFECTION AND LYMPHOMA
1012PDF: 545HTML: 7815 -
INTEREST IN DETERMINING THE CD34+ CD38- PHENOTYPE IN THE DIAGNOSIS AND PROGNOSIS OF ACUTE LEUKEMIA IN ABIDJAN – CÔTE D’IVOIRE
1987PDF: 725HTML: 688Table1: patient's characteristics: 157Table 2: profile of each patient: 180 -
PREVALENCE OF SICKLE CELL TRAIT IN THE SOUTHERN SUBURBS OF BEIRUT, LEBANON
4144PDF: 1014HTML: 19170 -
THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION
4144PDF: 1963HTML: 1772 -
CAR-T CELL THERAPY FOR T-CELL MALIGNANCIES CAR-T CELL FOR T-CELL MALIGNANCIES
2213PDF: 2047HTML: 195 -
-
A SEROPREVALENCE OF HBV, HCV AND HIV-1 AND CORRELATION WITH MOLECULAR MARKERS AMONG MULTI-TRANSFUSED THALASSEMIA PATIENTS IN WESTERN INDIA Incidence of serology & molecular of HIV, HBV and HCV in thalassemia patients
1362PDF: 765HTML: 522 -
HEMOGLOBIN ANALYSIS IN THE FIRST YEAR OF LIFE
3496PDF: 1035HTML: 3049 -
INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?
3245PDF: 1015HTML: 2031 -
JUSTIFICATION OF UNIVERSAL IRON SUPPLEMENTATION FOR INFANTS 6-12 MONTHS IN REGIONS WITH A HIGH PREVALENCE OF THALASSEMIA Iron Supplementation for Infants 6-12 months in Regions with a High Prevalence of Thalassemia
2262PDF: 613Suppl. Files: 284HTML: 175 -







